You are viewing the site in preview mode
Skip to main content
| |
RELN
|
P
|
|---|
|
Total
|
|
Control (48)
|
1.25 ± 0.13
| |
|
SCZ (30)
|
0.86 ± 0.09
|
0.0476 a
|
|
SCZ_12W (30)
|
1.32 ± 0.15
|
0.0384 b
|
|
Female
|
|
Control (31)
|
1.20 ± 0.14
| |
|
SCZ (16)
|
0.64 ± 0.07
|
0.0025 a
|
|
SCZ_12W (16)
|
1.33 ± 0.24
|
0.0507 b
|
|
Male
|
|
Control (17)
|
1.35 ± 0.28
| |
|
SCZ (14)
|
1.10 ± 0.16
|
0.9844 a
|
|
SCZ_12W (14)
|
1.32 ± 0.17
|
0.3575 b
|
- Abbreviations: Control Healthy control, SCZ Untreated schizophrenia patients, SCZ_12w Schizophrenia patients after 12 weeks of antipsychotic treatment; a: comparisons between the untreated schizophrenia patients and healthy control (Mann-Whitney U test); b: comparisons between the schizophrenia patients after 12 weeks of antipsychotic treatment and untreated schizophrenia patients (paired Wilcoxon signed-rank test); Bold figures indicate P < 0.05